A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Knight, MD
Celgene Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
69 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
- Peter Maccallum Cancer Centre Divsion of Haematology/medical Oncology
East Melbourne, Victoria, Australia
- the Alfred Hospital
Prahran, Victoria, Australia
- Border Medical Oncology
Wodonga, Victoria, Australia
- Box Hill Hospital
Box Hill, Australia
- Frankston Hospital Oncology Research
Frankston, Australia
- Royal Brisbane Hospital
Herston, Australia
- the Royal Melbourne Hospital
Parkville, Australia
- Mater Public Hospital
South Brisbane, Australia
- University Hospital of Salzburg St Johanns Spital
Salzburg, Austria
- Wilhelminenspital
Vienna, Austria
- Chu Saint-Luc
Brussels, Belgium
- Uz Gasthuisberg
Leuven, Belgium
- Centre Hospitalier Lyon Sud
Chemin Grand Revoyet, France
- Hopital Claude Huriez
Lille, France
- Centre Hospitalier Hotel-Dieu
Nantes, France
- Hopital Saint-Loius
Paris, France
- Chu de Bordeaux Groupe Hospitalier Sud
Pessac, France
- Chu Purpan
Toulouse, France
- Chu Nancy - Hopital Brabois
Vandœuvre-lès-Nancy, France
- Universitaetsklinikum Charite
Berlin, Germany
- Universitatsklinik Charitemedizinische Fakultaet Der Humboldtuniversitaet Zu Berlin
Berlin, Germany
- Universitaetsklinikum Dusseldorf Klinik Fuer Haematologie
Düsseldorf, Germany
- Universitaetsklinkum Erlangen
Erlangen, Germany
- Klininkum Der Johann-Wolfgang-Goethe-Universtat
Frankfurt am Main, Germany
- Universitaetsklinikum Heidelberg Medizinische Klinik Und Poliklinik V
Heidelberg, Germany
- Klinikum Der Univeristact Muenchen
München, Germany
- Universitatsklinik Muenster Medizinische Klinik A
Münster, Germany
- Universitaetsklinikum Tuebingen
Tübingen, Germany
- "alexandras" General Hospital of Athens
Athens, Greece
- University Hospital Galwayhaematology Department
Galway, Co. Galway, Ireland
- Belfast City Hospitalhaematology Department
Belfast, Ireland
- Hope Directorate Haematology Oncology Service St. James Hospital
Dublin, Ireland
- Midwestern Regional Hospital
Limerick, Ireland
- Rambam Medical Center
Haifa, Israel
- Hadassah University Hospital
Jerusalem, Israel
- Tel Aviv Sourasky Medical Center Department of Hematology
Tel Aviv, Israel
- the Chaim Sheba Medical Center
Tel Litwinsky, Israel
- Policlinico Sant'Orsola-Malpighi
Bologna, Italy
- Azienda Ospedaliera San Martino
Genova, Italy
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jan 2003
- Primary completion
- 1 Nov 2005
- Completion
- 12 Nov 2013
- Last update posted
- 19 Oct 2017
- Registered enrollment
- 351
- Registry id
- NCT00424047
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.